FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and potential cures for chronic ...

A new study reveals that inflammation during pregnancy may impair neurodevelopment in infants by reducing CD11c-positive ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Researchers at The University of Texas at Dallas have invented a new, inexpensive method for fabricating artificial muscles ...

Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data ...

Microglia dysfunction and cell death in the brain not only paralleled vascular inflammation, but also marked sites of damage to synapses and myelin sheaths that play a crucial role in neuronal ...

Background: This review examines novel interaction mechanisms contributing to the robustness of circadian rhythms, focusing on enhanced communication between the suprachiasmatic nucleus (SCN) and ...

Elon Musk has shared a video of re-designed Tesla's new Model Y on X, formerly known as Twitter. The Model Y offers innovative storage solutions with power-reclining seats and an expanded cargo ...

In people with multiple sclerosis (MS), lesions that get slowly bigger over time, potentially due to chronic inflammation, are associated with more myelin loss throughout the brain, a study found.

Just two months after the tech world was upended by the DeepSeek-R1 AI model, Alibaba Cloud has introduced QwQ-32B, an open source large language model (LLM). The Chinese cloud giant describes the ...

Tesla's revamped Model Y has racked up 200,000 orders since it opened for pre-orders on January 10, albeit including many refundable orders, according to local media. One of Tesla's core goals in ...

Chinese tech giant Alibaba unveiled its latest artificial intelligence reasoning model on Thursday, boasting that its capabilities beat those of rival models from OpenAI and startup DeepSeek.